1 – 31 of 31
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Antiretroviral treatment for HIV infection : Swedish recommendations 2019
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations
(
- Contribution to journal › Article
-
Mark
Increase in transmitted drug resistance in migrants from sub-Saharan Africa diagnosed with HIV-1 in Sweden
(
- Contribution to journal › Article
- 2017
-
Mark
Sweden, the first country to achieve the Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO) 90-90-90 continuum of HIV care targets
(
- Contribution to journal › Article
-
Mark
Vaccination against hepatitis B virus among people who inject drugs – A 20 year experience from a Swedish needle exchange program
(
- Contribution to journal › Article
-
Mark
Effect of therapy switch on time to second-line antiretroviral treatment failure in HIV-infected patients
(
- Contribution to journal › Article
- 2016
-
Mark
Viral blips during suppressive antiretroviral treatment are associated with high baseline HIV-1 RNA levels
(
- Contribution to journal › Article
-
Mark
Infection-related and -unrelated malignancies, HIV and the aging population
(
- Contribution to journal › Article
- 2015
-
Mark
Six-week follow-up after HIV-1 exposure: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy.
(
- Contribution to journal › Article
- 2014
-
Mark
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2013
(
- Contribution to journal › Scientific review
-
Mark
Risk of HIV transmission from patients on antiretroviral therapy: A position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Lopinavir/ritonavir, atazanavir/ritonavir, and efavirenz in antiretroviral-naive HIV-1-infected individuals over 144 weeks: An open-label randomized controlled trial
(
- Contribution to journal › Article
- 2012
-
Mark
Prevalence of sexually transmitted infections among women attending antenatal clinics in Tanga, north eastern Tanzania
(
- Contribution to journal › Article
- 2011
-
Mark
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish Recommendations 2010
(
- Contribution to journal › Scientific review
-
Mark
Bilirubin-A Potential Marker of Drug Exposure in Atazanavir-Based Antiretroviral Therapy
(
- Contribution to journal › Article
-
Mark
Non-linear mixed effects modeling of antiretroviral drug response after administration of lopinavir, atazanavir and efavirenz containing regimens to treatment-naive HIV-1 infected patients
(
- Contribution to journal › Article
-
Mark
Minimal transmission of HIV despite persistently high transmission of hepatitis C virus in a Swedish needle exchange program.
(
- Contribution to journal › Article
- 2010
-
Mark
The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-na
- Contribution to journal › Article
-
Mark
Differential Effects of Efavirenz, Lopinavir/r, and Atazanavir/r on the Initial Viral Decay Rate in Treatment Naive HIV-1-Infected Patients
(
- Contribution to journal › Article
-
Mark
Increased risk of abdominal wall hernia associated with combination anti-retroviral therapy in HIV-infected patients-results from a Swedish cohort-study
(
- Contribution to journal › Article
- 2009
-
Mark
CONTINUED HEAVY TRANSMISSION OF HCV IN A NEEDLE EXCHANGE PROGRAM THAT IS ASSOCIATED WITH MINIMAL TRANMISSION OF HIV. A NINE YEAR LONGITUDINAL COHORT STUDY
2009) 44th Annual Meeting of the European-Association-for-the-Study-of-the-Liver In Journal of Hepatology 50(Suppl 1). p.161-161(
- Contribution to journal › Published meeting abstract
-
Mark
Treatment of HIV infection: Swedish recommendations 2009
(
- Contribution to journal › Scientific review
- 2008
-
Mark
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2007
(
- Contribution to journal › Scientific review
-
Mark
CYP3A induction and inhibition by different antiretroviral regimens reflected by changes in plasma 4 beta-hydroxycholesterol levels
(
- Contribution to journal › Article
-
Mark
Once-daily fosamprenavir with ritonavir in the treatment of HIV infection in therapy-naïve patients.
(
- Contribution to journal › Article
- 2007
-
Mark
Enhanced and resumed GB virus C replication in HIV-1-infected individuals receiving HAART.
(
- Contribution to journal › Article
- 2004
-
Mark
GB virus C viraemia and HIV progression: cause or effect?
(
- Contribution to journal › Letter
-
Mark
GB virus C and survival in persons with HIV infection
(
- Contribution to journal › Letter
-
Mark
GB virus C during the natural course of HIV-1 infection: viremia at diagnosis does not predict mortality.
(
- Contribution to journal › Article
- 2003
-
Mark
Follow-up of antiretroviral treatment in liver transplant recipients with primary and chronic HIV type 1 infection
(
- Contribution to journal › Article
- 1992
-
Mark
Herpes simplex virus--the most frequently isolated pathogen in the lungs of patients with severe respiratory distress
(
- Contribution to journal › Article